Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.05

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8364)	5/15/2003 9:58:19 AM
From: Biotech Jim	Read Replies (1) of 52153

<I could conceive of a cocktail of siRNA's tailored to inhibit the offending genes.> As you know, Peter, the FDA does not deal with the cocktail issue, since each "drug" needs to show efficacy on its own and needs approval prior to use in combo therapy. Now for treating cancer in rats... BJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next